API,Velpatasvir,cas:1377049-84-7 CAS NO.1377049-84-7
- FOB Price: USD: 60.00-75.00 /Gram Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: L/C,D/A,D/P,T/T,
- Available Specifications:
99%(1-200)Gram99%(200-5000)Gram
- Product Details
Keywords
- 1377049-84-7
- Velpatasvir
- API
Quick Details
- ProName: API,Velpatasvir,cas:1377049-84-7
- CasNo: 1377049-84-7
- Molecular Formula: C49H54N8O8
- Appearance: white powder
- Application: Velpatasvir is used for treat Hepatiti...
- DeliveryTime: Shipped in 15 days after payment
- PackAge: according to customers' requirements
- Port: China main port
- ProductionCapacity: 10000 Metric Ton/Month
- Purity: 99%
- Transportation: Air, sea, land transport
- LimitNum: 1 Gram
Superiority
Velpatasvir is a Direct-Acting Antiviral (DAA) medication used as part of combination therapy to treat chronic Hepatitis C, an infectious liver disease caused by infection with Hepatitis C Virus (HCV). Velpatasvir has a significantly higher barrier to resistance than the first generation NS5A inhibitors, such as Ledipasvir and Daclatasvir, making it a highly potent and reliable alternative for treatment of chronic Hepatitis C.Velpatasvir is currently only available within a fixed dose combination product as Epclusa with Sofosbuvir, another direct acting antiviral.
Details
Product name |
Velpatasvir |
Synonyms |
Velpatasvir |
CAS No. |
1377049-84-7 |
Molecular formula |
C49H54N8O8 |
Molecular weight |
883.01 |
Appearance |
White powder |
Assay |
99%min |
Packing |
100G/bag,1Kg/bag or as demand |
Application |
APIs |
1. Velpatasvir is used for treat Hepatitis C virus.
2. Is a Direct-Acting Antiviral (DAA) medication used as part of combination therapy to treat chronic Hepatitis C, an infectious liver disease caused by infection with Hepatitis C Virus (HCV).
3. such as Ledipasvir and Daclatasvir, making it a highly potent and reliable alternative for treatment of chronic Hepatitis C.